Concure Oncology Overview

  • Year Founded
  • 2014

Year Founded

  • Status
  • Out of Business

  • Employees
  • 6

Employees

  • Latest Deal Type
  • Out of Business

Concure Oncology General Information

Description

Developer of radiation-based oncology treatment designed to cure breast cancers in women. The company offers early diagnosis and treatment of breast cancer, and medical institutions to break down geographic and technological barriers to breast cancer radiation treatment, enabling women to get rid of early-stage breast cancer by enhancing and simplifying radiation treatment.

Contact Information

Formerly Known As
Breast Microseed
Ownership Status
Out of Business
Financing Status
Formerly VC-backed
Corporate Office
  • 3010 77th Avenue South East
  • Suite 206
  • Mercer Island, WA 98040
  • United States
+1 (206) 000-0000
Primary Industry
Clinics/Outpatient Services
Vertical(s)
Life Sciences, Oncology
Corporate Office
  • 3010 77th Avenue South East
  • Suite 206
  • Mercer Island, WA 98040
  • United States
+1 (206) 000-0000

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Concure Oncology Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
7. Out of Business 09-Feb-2023 000.00 Completed Out of Business
6. Later Stage VC 01-Apr-2022 00.000 000.00 Completed Generating Revenue
5. Later Stage VC 29-Oct-2020 00.00 000.00 Completed Generating Revenue
4. Debt - PPP 15-Apr-2020 00000 00.000 Completed Generating Revenue
3. Angel (individual) 000 00.000 Completed Generating Revenue
2. Seed Round 04-Dec-2015 $2M $2.55M Completed Generating Revenue
1. Angel (individual) 12-May-2014 $550K $550K Completed Startup
To view Concure Oncology’s complete valuation and funding history, request access »

Concure Oncology Patents

Concure Oncology Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
EP-2421433-B1 Brachytherapy fiducial needle fixation system Active 21-Apr-2009 0000000000
EP-2421433-A1 Brachytherapy fiducial needle fixation system and method Active 21-Apr-2009 0000000000 0
EP-2421433-A4 Brachytherapy fiducial needle fixation system and method Active 21-Apr-2009 A61N5/1007 0

Concure Oncology Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Concure Oncology FAQs

  • When was Concure Oncology founded?

    Concure Oncology was founded in 2014.

  • Who is the founder of Concure Oncology?

    Kevin Kelley, Sandra Rorem, and Ralph Pascualy MD are the founders of Concure Oncology.

  • Where is Concure Oncology headquartered?

    Concure Oncology is headquartered in Mercer Island, WA.

  • What is the size of Concure Oncology?

    Concure Oncology has 6 total employees.

  • What industry is Concure Oncology in?

    Concure Oncology’s primary industry is Clinics/Outpatient Services.

  • Is Concure Oncology a private or public company?

    Concure Oncology is a Private company.

  • What is Concure Oncology’s current revenue?

    The current revenue for Concure Oncology is 000000.

  • How much funding has Concure Oncology raised over time?

    Concure Oncology has raised $21.4M.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »